August 2018 PMID 30230624

Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going.

Aldo Quattrone, Gaetano Barbagallo, Antonio Cerasa, A Jon Stoessl

Mentions

10
Peak: 2 in Aug 2023
across 4 sources since Apr 2021

Extended reach

4,875
potential audience

Total likes

131

Video views

4,620

Mentions per month

Apr 2021 – Oct 2024

Where it's discussed

  • X / Twitter4 posts
  • YouTube2 videos
  • News2 articles
  • Blogs2 articles

AI synopsis

What people are saying

The overall tone indicates recognition of the importance of the research, as seen in tweets urging thorough study before commenting and highlighting the complexity of placebo effects, such as references to the neural pathways involved and calls to understand the literature better. Words like 'study,' 'complex,' and 'more knowledge' reflect a cautious yet engaged attitude, emphasizing the ongoing development of understanding in this area.

AgreementModerate agreement

Most posts acknowledge the importance of understanding the neurobiology behind the placebo effect, though some suggest more research is needed before drawing conclusions.

InterestModerate interest

Discussions show a moderate level of interest, with some participants emphasizing the complexity of the subject and calling for further study.

EngagementNeutral engagement

Engagement appears cautious, with comments pointing out the need for more knowledge rather than deep analysis or critique.

ImpactModerate impact

While the posts highlight the significance of neuroscientific insights, they do not reflect widespread enthusiasm or transformative implications at this stage.

Abstract in brief

  • The neurobiological basis of the placebo effect in Parkinson's disease involves dopamine release in the brain's striatal pathways, which can lead to motor improvement.
  • Studies show that the strength of placebo responses depends on patients' expectations of improvement, linked to dopamine release in the ventral striatum, and can be influenced by previous experiences and learning.
  • While the neural networks involved are mostly understood, ongoing research aims to clarify how the expectation of reward interacts with motor pathways to produce clinical benefits.

Top posts

Most liked on X and Bluesky
MFPL
@MFPL6 · X

@jonatanpallesen @laurenatlas It's more conplex for everything. Check the Neurobiology of placebo effects in Parkinson disease: https://t.co/9Ywk6PJ9u3 You're conclusions are based on the lack of knowlange of placebo literature.

Aug 23, 2023 · 2 likes · 59 followers View post →
Victor Mark
@vwminala · X

@LilithJezebel @GDB56DAY @IvanasStairCam @RepMTG https://t.co/DEVD8LSACz

Jan 21, 2024 · 85 followers View post →
MFPL
@MFPL6 · X

@qevnir @jonatanpallesen Check also the Neurobiology of placebos in Parkinson disease: https://t.co/9Ywk6PJ9u3 People should study before writing a tweet.

Aug 23, 2023 · 59 followers View post →
El_Sturm
@Lowtour · X

@Maxime25566728 @2vanssay Désolé si je vous ai paru condescendant. https://t.co/dmQzQvCdI5

Jan 14, 2023 · 52 followers View post →

All mentions

Victor Mark
@vwminala · X

@LilithJezebel @GDB56DAY @IvanasStairCam @RepMTG https://t.co/DEVD8LSACz

Jan 21, 2024 · 85 followers View post →
MFPL
@MFPL6 · X

@qevnir @jonatanpallesen Check also the Neurobiology of placebos in Parkinson disease: https://t.co/9Ywk6PJ9u3 People should study before writing a tweet.

Aug 23, 2023 · 59 followers View post →
MFPL
@MFPL6 · X

@jonatanpallesen @laurenatlas It's more conplex for everything. Check the Neurobiology of placebo effects in Parkinson disease: https://t.co/9Ywk6PJ9u3 You're conclusions are based on the lack of knowlange of placebo literature.

Aug 23, 2023 · 2 likes · 59 followers View post →
El_Sturm
@Lowtour · X

@Maxime25566728 @2vanssay Désolé si je vous ai paru condescendant. https://t.co/dmQzQvCdI5

Jan 14, 2023 · 52 followers View post →